No easy road to outsmart cancer
Hopes of greatly speeding up the evaluation of new therapies by using tumour response to a short course of neoadjuvant treatment as a surrogate for clinical benefit have proved false and the sooner we recognise [more]
Neoadjuvant
Neoadjuvant trial design: time for a brave new world?
In the NOAH clinical trial, trastuzumab treatment for locally advanced breast cancer, given prior to surgery, was associated with increased complete and overall response rate and improved event free survival.The ability to identify this advantage [more]
Balancing cure and care
Cornelis van de Velde went into cancer because he loved the complexity. Throughout his career he has grasped each new development across the disciplines to see how it could help resolve the difficult balance between [more]